ID   RHO_ECOLI               Reviewed;         419 AA.
AC   P0AG30; P03002; Q2M891; Q48357;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   21-JUL-1986, sequence version 1.
DT   07-JAN-2015, entry version 100.
DE   RecName: Full=Transcription termination factor Rho;
DE            EC=3.6.4.-;
DE   AltName: Full=ATP-dependent helicase Rho;
GN   Name=rho; Synonyms=nitA, psuA, rnsC, sbaA, tsu;
GN   OrderedLocusNames=b3783, JW3756;
OS   Escherichia coli (strain K12).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacteriales;
OC   Enterobacteriaceae; Escherichia.
OX   NCBI_TaxID=83333;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=K12;
RX   PubMed=6304634; DOI=10.1093/nar/11.11.3531;
RA   Pinkham J.L., Platt T.;
RT   "The nucleotide sequence of the rho gene of E. coli K-12.";
RL   Nucleic Acids Res. 11:3531-3545(1983).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / MG1655 / ATCC 47076;
RX   PubMed=1379743; DOI=10.1126/science.1379743;
RA   Daniels D.L., Plunkett G. III, Burland V.D., Blattner F.R.;
RT   "Analysis of the Escherichia coli genome: DNA sequence of the region
RT   from 84.5 to 86.5 minutes.";
RL   Science 257:771-778(1992).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / MG1655 / ATCC 47076;
RX   PubMed=9278503; DOI=10.1126/science.277.5331.1453;
RA   Blattner F.R., Plunkett G. III, Bloch C.A., Perna N.T., Burland V.,
RA   Riley M., Collado-Vides J., Glasner J.D., Rode C.K., Mayhew G.F.,
RA   Gregor J., Davis N.W., Kirkpatrick H.A., Goeden M.A., Rose D.J.,
RA   Mau B., Shao Y.;
RT   "The complete genome sequence of Escherichia coli K-12.";
RL   Science 277:1453-1462(1997).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
RX   PubMed=16738553; DOI=10.1038/msb4100049;
RA   Hayashi K., Morooka N., Yamamoto Y., Fujita K., Isono K., Choi S.,
RA   Ohtsubo E., Baba T., Wanner B.L., Mori H., Horiuchi T.;
RT   "Highly accurate genome sequences of Escherichia coli K-12 strains
RT   MG1655 and W3110.";
RL   Mol. Syst. Biol. 2:E1-E5(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-196.
RX   PubMed=2423505;
RA   Matsumoto Y., Shigesada K., Hirano M., Imai M.;
RT   "Autogenous regulation of the gene for transcription termination
RT   factor rho in Escherichia coli: localization and function of its
RT   attenuators.";
RL   J. Bacteriol. 166:945-958(1986).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 397-419.
RX   PubMed=1722555; DOI=10.1111/j.1365-2958.1991.tb00809.x;
RA   Ohta M., Ina K., Kusuzaki K., Kido N., Arakawa Y., Kato N.;
RT   "Cloning and expression of the rfe-rff gene cluster of Escherichia
RT   coli.";
RL   Mol. Microbiol. 5:1853-1862(1991).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 405-419.
RX   PubMed=7828920; DOI=10.1016/0378-1119(94)00664-E;
RA   Opperman T., Martinez A., Richardson J.P.;
RT   "The ts15 mutation of Escherichia coli alters the sequence of the C-
RT   terminal nine residues of Rho protein.";
RL   Gene 152:133-134(1995).
RN   [8]
RP   PROTEIN SEQUENCE OF 1-12.
RC   STRAIN=K12 / EMG2;
RX   PubMed=9298646; DOI=10.1002/elps.1150180807;
RA   Link A.J., Robison K., Church G.M.;
RT   "Comparing the predicted and observed properties of proteins encoded
RT   in the genome of Escherichia coli K-12.";
RL   Electrophoresis 18:1259-1313(1997).
RN   [9]
RP   FUNCTION, AND RNA-BINDING DOMAIN.
RX   PubMed=1716628;
RA   Brennan C.A., Platt T.;
RT   "Mutations in an RNP1 consensus sequence of Rho protein reduce RNA
RT   binding affinity but facilitate helicase turnover.";
RL   J. Biol. Chem. 266:17296-17305(1991).
RN   [10]
RP   FUNCTION, AND MUTAGENESIS.
RX   PubMed=2461932;
RA   Dombroski A.J., Brennan C.A., Spear P., Platt T.;
RT   "Site-directed alterations in the ATP-binding domain of rho protein
RT   affect its activities as a termination factor.";
RL   J. Biol. Chem. 263:18802-18809(1988).
RN   [11]
RP   ENZYME REGULATION, BIOPHYSICOCHEMICAL PROPERTIES, AND MUTAGENESIS OF
RP   CYS-202.
RX   PubMed=7487110; DOI=10.1006/abbi.1995.0066;
RA   Park H.G., Zhang X., Moon H.S., Zwiefka A., Cox K., Gaskell S.J.,
RA   Widger W.R., Kohn H.;
RT   "Bicyclomycin and dihydrobicyclomycin inhibition kinetics of
RT   Escherichia coli rho-dependent transcription termination factor ATPase
RT   activity.";
RL   Arch. Biochem. Biophys. 323:447-454(1995).
RN   [12]
RP   IDENTIFICATION BY 2D-GEL.
RX   PubMed=9298644; DOI=10.1002/elps.1150180805;
RA   VanBogelen R.A., Abshire K.Z., Moldover B., Olson E.R.,
RA   Neidhardt F.C.;
RT   "Escherichia coli proteome analysis using the gene-protein database.";
RL   Electrophoresis 18:1243-1251(1997).
RN   [13]
RP   STRUCTURE BY NMR OF 1-130.
RX   PubMed=9008362; DOI=10.1007/BF00228145;
RA   Briercheck D.M., Allison T.J., Richardson J.P., Ellena J.F.,
RA   Wood T.C., Rule S.G.;
RT   "1H, 15N and 13C resonance assignments and secondary structure
RT   determination of the RNA-binding domain of E.coli rho protein.";
RL   J. Biomol. NMR 8:429-444(1996).
RN   [14]
RP   STRUCTURE BY NMR OF 1-130.
RX   PubMed=9587002; DOI=10.1038/nsb0598-393;
RA   Briercheck D.M., Allison T.J., Wood T.C., Richardson J.P., Rule G.S.;
RT   "The NMR structure of the RNA binding domain of E. coli rho factor
RT   suggests possible RNA-protein interactions.";
RL   Nat. Struct. Biol. 5:393-399(1998).
RN   [15]
RP   X-RAY CRYSTALLOGRAPHY (1.55 ANGSTROMS) OF 1-130, AND SUBUNIT.
RX   PubMed=9586995; DOI=10.1038/nsb0598-352;
RA   Allison T.J., Wood T.C., Briercheck D.M., Rastinejad F.,
RA   Richardson J.P., Rule G.S.;
RT   "Crystal structure of the RNA-binding domain from transcription
RT   termination factor rho.";
RL   Nat. Struct. Biol. 5:352-356(1998).
RN   [16]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 1-118 IN COMPLEX WITH POLY-C
RP   OLIGONUCLEOTIDE, INTERACTION WITH TARGET RNA, AND SUBUNIT.
RX   PubMed=10230401; DOI=10.1016/S1097-2765(00)80476-1;
RA   Bogden C.E., Fass D., Bergman N., Nichols M.D., Berger J.M.;
RT   "The structural basis for terminator recognition by the Rho
RT   transcription termination factor.";
RL   Mol. Cell 3:487-493(1999).
RN   [17]
RP   X-RAY CRYSTALLOGRAPHY (3.0 ANGSTROMS) IN COMPLEX WITH AMPPNP AND
RP   OLIGONUCLEOTIDE, AND SUBUNIT.
RX   PubMed=12859904; DOI=10.1016/S0092-8674(03)00512-9;
RA   Skordalakes E., Berger J.M.;
RT   "Structure of the Rho transcription terminator: mechanism of mRNA
RT   recognition and helicase loading.";
RL   Cell 114:135-146(2003).
RN   [18]
RP   X-RAY CRYSTALLOGRAPHY (3.05 ANGSTROMS) IN COMPLEX WITH INHIBITOR
RP   BICYCLOMYCIN; MAGNESIUM-ATP ANALOG AND OLIGO-U OLIGONUCLEOTIDE, AND
RP   SUBUNIT.
RX   PubMed=15642265; DOI=10.1016/j.str.2004.10.013;
RA   Skordalakes E., Brogan A.P., Park B.S., Kohn H., Berger J.M.;
RT   "Structural mechanism of inhibition of the Rho transcription
RT   termination factor by the antibiotic bicyclomycin.";
RL   Structure 13:99-109(2005).
RN   [19]
RP   X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) IN COMPLEX WITH POLY-U
RP   OLIGONUCLEOTIDE; ADP; MAGNESIUM AND BERYLLIUM IONS, AND SUBUNIT.
RX   PubMed=19879839; DOI=10.1016/j.cell.2009.08.043;
RA   Thomsen N.D., Berger J.M.;
RT   "Running in reverse: the structural basis for translocation polarity
RT   in hexameric helicases.";
RL   Cell 139:523-534(2009).
CC   -!- FUNCTION: Facilitates transcription termination by a mechanism
CC       that involves Rho binding to the nascent RNA, activation of Rho's
CC       RNA-dependent ATPase activity, and release of the mRNA from the
CC       DNA template. RNA-dependent NTPase which utilizes all four
CC       ribonucleoside triphosphates as substrates.
CC       {ECO:0000269|PubMed:1716628, ECO:0000269|PubMed:2461932}.
CC   -!- ENZYME REGULATION: ATPase activity is inhibited by bicyclomycin
CC       and dihydrobicyclomycin. {ECO:0000269|PubMed:7487110}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=11 uM for ATP {ECO:0000269|PubMed:7487110};
CC   -!- SUBUNIT: Homohexamer. The homohexamer assembles into an open ring
CC       structure. {ECO:0000269|PubMed:10230401,
CC       ECO:0000269|PubMed:12859904, ECO:0000269|PubMed:15642265,
CC       ECO:0000269|PubMed:19879839, ECO:0000269|PubMed:9586995}.
CC   -!- INTERACTION:
CC       Self; NbExp=3; IntAct=EBI-545468, EBI-545468;
CC       P0AES0:gss; NbExp=4; IntAct=EBI-545468, EBI-557080;
CC       P0A6X3:hfq; NbExp=4; IntAct=EBI-545468, EBI-547637;
CC       P0AFG0:nusG; NbExp=6; IntAct=EBI-545468, EBI-369628;
CC       P0AFW8:rof; NbExp=2; IntAct=EBI-545468, EBI-1114609;
CC   -!- DOMAIN: Each subunit has two RNA-binding sites, one at the surface
CC       of the hexameric ring, and one at the center of the open ring
CC       structure, where RNA helicase activity is thought to take place.
CC   -!- SIMILARITY: Belongs to the Rho family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; J01673; AAA24532.1; -; Genomic_DNA.
DR   EMBL; M87049; AAA67583.1; -; Genomic_DNA.
DR   EMBL; U00096; AAC76788.1; -; Genomic_DNA.
DR   EMBL; AP009048; BAE77515.1; -; Genomic_DNA.
DR   EMBL; M12779; AAA24695.1; -; Genomic_DNA.
DR   EMBL; S75640; AAB20841.1; -; Genomic_DNA.
DR   EMBL; L34404; AAA68985.1; -; Genomic_DNA.
DR   PIR; A03530; TWECR.
DR   RefSeq; NP_418230.1; NC_000913.3.
DR   RefSeq; YP_491656.1; NC_007779.1.
DR   PDB; 1A62; X-ray; 1.55 A; A=1-130.
DR   PDB; 1A63; NMR; -; A=1-130.
DR   PDB; 1A8V; X-ray; 2.00 A; A/B=1-118.
DR   PDB; 1PV4; X-ray; 3.00 A; A/B/C/D/E/F=1-419.
DR   PDB; 1PVO; X-ray; 3.00 A; A/B/C/D/E/F=1-419.
DR   PDB; 1XPO; X-ray; 3.15 A; A/B/C/D/E/F=1-419.
DR   PDB; 1XPR; X-ray; 3.15 A; A/B/C/D/E/F=1-419.
DR   PDB; 1XPU; X-ray; 3.05 A; A/B/C/D/E/F=1-419.
DR   PDB; 2A8V; X-ray; 2.40 A; A/B/C=1-118.
DR   PDB; 2HT1; X-ray; 3.51 A; A/B=1-411.
DR   PDB; 3ICE; X-ray; 2.80 A; A/B/C/D/E/F=1-419.
DR   PDBsum; 1A62; -.
DR   PDBsum; 1A63; -.
DR   PDBsum; 1A8V; -.
DR   PDBsum; 1PV4; -.
DR   PDBsum; 1PVO; -.
DR   PDBsum; 1XPO; -.
DR   PDBsum; 1XPR; -.
DR   PDBsum; 1XPU; -.
DR   PDBsum; 2A8V; -.
DR   PDBsum; 2HT1; -.
DR   PDBsum; 3ICE; -.
DR   ProteinModelPortal; P0AG30; -.
DR   SMR; P0AG30; 1-415.
DR   DIP; DIP-35363N; -.
DR   IntAct; P0AG30; 64.
DR   MINT; MINT-1222551; -.
DR   STRING; 511145.b3783; -.
DR   PaxDb; P0AG30; -.
DR   PRIDE; P0AG30; -.
DR   EnsemblBacteria; AAC76788; AAC76788; b3783.
DR   EnsemblBacteria; BAE77515; BAE77515; BAE77515.
DR   GeneID; 12930703; -.
DR   GeneID; 948297; -.
DR   KEGG; ecj:Y75_p3392; -.
DR   KEGG; eco:b3783; -.
DR   PATRIC; 32123057; VBIEscCol129921_3898.
DR   EchoBASE; EB0838; -.
DR   EcoGene; EG10845; rho.
DR   eggNOG; COG1158; -.
DR   HOGENOM; HOG000076952; -.
DR   InParanoid; P0AG30; -.
DR   KO; K03628; -.
DR   OMA; DYNYLPG; -.
DR   OrthoDB; EOG6N681W; -.
DR   PhylomeDB; P0AG30; -.
DR   BioCyc; EcoCyc:EG10845-MONOMER; -.
DR   BioCyc; ECOL316407:JW3756-MONOMER; -.
DR   EvolutionaryTrace; P0AG30; -.
DR   PRO; PR:P0AG30; -.
DR   Proteomes; UP000000318; Chromosome.
DR   Proteomes; UP000000625; Chromosome.
DR   Genevestigator; P0AG30; -.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-HAMAP.
DR   GO; GO:0004386; F:helicase activity; IEA:UniProtKB-HAMAP.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0003723; F:RNA binding; IDA:EcoCyc.
DR   GO; GO:0008186; F:RNA-dependent ATPase activity; IEA:InterPro.
DR   GO; GO:0006353; P:DNA-templated transcription, termination; IDA:EcoCyc.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW.
DR   GO; GO:0006351; P:transcription, DNA-templated; IDA:EcoCyc.
DR   Gene3D; 2.40.50.140; -; 1.
DR   Gene3D; 3.40.50.300; -; 1.
DR   HAMAP; MF_01884; Rho; 1.
DR   InterPro; IPR003593; AAA+_ATPase.
DR   InterPro; IPR000194; ATPase_F1/V1/A1_a/bsu_nucl-bd.
DR   InterPro; IPR011129; Cold_shock_prot.
DR   InterPro; IPR012340; NA-bd_OB-fold.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR011112; Rho_N.
DR   InterPro; IPR011113; Rho_RNA-bd.
DR   InterPro; IPR004665; Term_rho.
DR   Pfam; PF00006; ATP-synt_ab; 1.
DR   Pfam; PF07498; Rho_N; 1.
DR   Pfam; PF07497; Rho_RNA_bind; 1.
DR   SMART; SM00382; AAA; 1.
DR   SMART; SM00357; CSP; 1.
DR   SMART; SM00959; Rho_N; 1.
DR   SUPFAM; SSF50249; SSF50249; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   SUPFAM; SSF68912; SSF68912; 1.
DR   TIGRFAMs; TIGR00767; rho; 1.
PE   1: Evidence at protein level;
KW   3D-structure; ATP-binding; Complete proteome;
KW   Direct protein sequencing; Helicase; Hydrolase; Nucleotide-binding;
KW   Reference proteome; RNA-binding; Transcription;
KW   Transcription regulation; Transcription termination.
FT   CHAIN         1    419       Transcription termination factor Rho.
FT                                /FTId=PRO_0000188962.
FT   NP_BIND     169    174       ATP. {ECO:0000255}.
FT   NP_BIND     181    186       ATP.
FT   REGION       61     66       RNA-binding 1.
FT   REGION       78     80       RNA-binding 1.
FT   REGION      108    110       RNA-binding 1.
FT   REGION      284    288       RNA-binding 2.
FT   BINDING     212    212       ATP.
FT   SITE        326    326       RNA-binding 2.
FT   MUTAGEN      62     62       F->L,A: Defective for RNA-binding.
FT                                {ECO:0000269|PubMed:2461932}.
FT   MUTAGEN      64     64       F->L,A: Defective for RNA-binding.
FT                                {ECO:0000269|PubMed:2461932}.
FT   MUTAGEN     181    181       K->Q: Partial loss of ATPase, helicase
FT                                and termination activity.
FT                                {ECO:0000269|PubMed:2461932}.
FT   MUTAGEN     184    184       K->Q: Improves ATPase and helicase
FT                                activity but reduced termination
FT                                activity. {ECO:0000269|PubMed:2461932}.
FT   MUTAGEN     202    202       C->G,S: Does not affect the kinetics of
FT                                ATP hydrolysis and inhibition by
FT                                bicyclomycin.
FT                                {ECO:0000269|PubMed:7487110}.
FT   MUTAGEN     265    265       D->N: Loss of ATPase activity, helicase
FT                                and termination activity.
FT                                {ECO:0000269|PubMed:2461932}.
FT   CONFLICT    411    419       DFFEMMKRS -> EVMTPTY (in Ref. 7;
FT                                AAA68985). {ECO:0000305}.
FT   HELIX         3      7       {ECO:0000244|PDB:1A62}.
FT   HELIX        11     19       {ECO:0000244|PDB:1A62}.
FT   TURN         20     22       {ECO:0000244|PDB:1A62}.
FT   HELIX        26     28       {ECO:0000244|PDB:1A8V}.
FT   HELIX        31     44       {ECO:0000244|PDB:1A62}.
FT   STRAND       49     57       {ECO:0000244|PDB:1A62}.
FT   STRAND       59     61       {ECO:0000244|PDB:1XPU}.
FT   STRAND       63     66       {ECO:0000244|PDB:1A62}.
FT   HELIX        68     70       {ECO:0000244|PDB:1A62}.
FT   HELIX        75     77       {ECO:0000244|PDB:1A8V}.
FT   STRAND       79     81       {ECO:0000244|PDB:1A62}.
FT   HELIX        83     88       {ECO:0000244|PDB:1A62}.
FT   STRAND       96    102       {ECO:0000244|PDB:1A62}.
FT   STRAND      105    107       {ECO:0000244|PDB:1A63}.
FT   STRAND      110    119       {ECO:0000244|PDB:1A62}.
FT   HELIX       124    127       {ECO:0000244|PDB:3ICE}.
FT   TURN        133    135       {ECO:0000244|PDB:3ICE}.
FT   STRAND      138    140       {ECO:0000244|PDB:3ICE}.
FT   STRAND      142    144       {ECO:0000244|PDB:1PV4}.
FT   HELIX       156    165       {ECO:0000244|PDB:3ICE}.
FT   STRAND      169    171       {ECO:0000244|PDB:1XPO}.
FT   STRAND      173    177       {ECO:0000244|PDB:3ICE}.
FT   STRAND      180    183       {ECO:0000244|PDB:3ICE}.
FT   HELIX       184    198       {ECO:0000244|PDB:3ICE}.
FT   STRAND      202    211       {ECO:0000244|PDB:3ICE}.
FT   HELIX       213    220       {ECO:0000244|PDB:3ICE}.
FT   STRAND      224    230       {ECO:0000244|PDB:3ICE}.
FT   HELIX       236    255       {ECO:0000244|PDB:3ICE}.
FT   STRAND      259    265       {ECO:0000244|PDB:3ICE}.
FT   HELIX       267    277       {ECO:0000244|PDB:3ICE}.
FT   STRAND      286    288       {ECO:0000244|PDB:3ICE}.
FT   HELIX       291    301       {ECO:0000244|PDB:3ICE}.
FT   STRAND      305    310       {ECO:0000244|PDB:3ICE}.
FT   STRAND      312    319       {ECO:0000244|PDB:3ICE}.
FT   STRAND      322    324       {ECO:0000244|PDB:3ICE}.
FT   HELIX       326    338       {ECO:0000244|PDB:3ICE}.
FT   STRAND      340    345       {ECO:0000244|PDB:3ICE}.
FT   HELIX       347    351       {ECO:0000244|PDB:3ICE}.
FT   TURN        360    362       {ECO:0000244|PDB:3ICE}.
FT   STRAND      364    367       {ECO:0000244|PDB:3ICE}.
FT   HELIX       368    370       {ECO:0000244|PDB:3ICE}.
FT   HELIX       374    387       {ECO:0000244|PDB:3ICE}.
FT   HELIX       392    401       {ECO:0000244|PDB:3ICE}.
FT   TURN        402    405       {ECO:0000244|PDB:3ICE}.
FT   HELIX       408    414       {ECO:0000244|PDB:3ICE}.
SQ   SEQUENCE   419 AA;  47004 MW;  5970A85334C43467 CRC64;
     MNLTELKNTP VSELITLGEN MGLENLARMR KQDIIFAILK QHAKSGEDIF GDGVLEILQD
     GFGFLRSADS SYLAGPDDIY VSPSQIRRFN LRTGDTISGK IRPPKEGERY FALLKVNEVN
     FDKPENARNK ILFENLTPLH ANSRLRMERG NGSTEDLTAR VLDLASPIGR GQRGLIVAPP
     KAGKTMLLQN IAQSIAYNHP DCVLMVLLID ERPEEVTEMQ RLVKGEVVAS TFDEPASRHV
     QVAEMVIEKA KRLVEHKKDV IILLDSITRL ARAYNTVVPA SGKVLTGGVD ANALHRPKRF
     FGAARNVEEG GSLTIIATAL IDTGSKMDEV IYEEFKGTGN MELHLSRKIA EKRVFPAIDY
     NRSGTRKEEL LTTQEELQKM WILRKIIHPM GEIDAMEFLI NKLAMTKTND DFFEMMKRS
//
